Welcome to UK420

Register now to gain access to all of our features. Once registered and logged in, you will be able to contribute to this site by submitting your own content or replying to existing content. You'll be able to customize your profile, receive reputation points as a reward for submitting content, while also communicating with other members via your own private inbox, plus much more!

This message will be removed once you have signed in.

Search the Community: Showing results for tags 'world'.

More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


  • Welcome to UK420
    • New Members
    • Announcements
  • Cultivation
    • Strain Base
    • Breeders Help Desks
    • Compost and Pots
    • Hydroponics
    • Outdoor Growing
    • Propagation, Cloning and Mother Plants
    • Auto Flowering
    • Growroom Design
    • Problem Solver
    • Harvesting and Processing
    • Grow Diaries
    • Cream Of The Crop
  • Cannabis Culture
    • News, Views and Politics
    • Medicinal Cannabis
    • Smokers Lounge
    • Uk420 Competitions
  • Sponsor Support
    • Grow and Harvest
    • Intense Nutrients
    • Vapefiend - The Vaporizer Specialists
    • DIY LED UK
  • Community Lifestyle
    • Green Living
    • Gardening
    • Growers Wives Club
    • Creative Arts
    • Food & Drink
    • Travel
    • Sport


  • Community Calendar

Found 88 results

  1. hi Can using cannabis help lower my cholesterol? Studies have raised interesting points about marijuana’s potential role Millions of Americans live with high cholesterol, which can increase the risk of developing heart disease, developing peripheral artery disease, or having a stroke – all of which are potentially life-threatening. Research is being conducted to determine whether patients with high cholesterol could see health benefits from using marijuana. So far, scientists haven’t reached a conclusive verdict about whether cannabis can lower cholesterol, but while more research is needed, existing studies have raised some interesting points about marijuana’s potential role in the fight against high cholesterol and cardiovascular disease. Marijuana Can Lower, Raise Good Cholesterol (HDL) Cholesterol is an organic compound that naturally exists in all of your body’s cells. Cholesterol is critical to various bodily functions, such as synthesizing vitamin D, making hormones, and producing substances your body needs to digest food properly. But while some cholesterol is essential to life, too much can wreak havoc on your health. According to the CDC, about 73.5 million American adults – roughly a third of the population – have high cholesterol, which can double the risk of developing cardiovascular disease. A 2013 study published in Diabetes Care examined the relationship between cannabis use, cholesterol levels, glucose (blood sugar), and insulin (a hormone that helps moderate glucose levels). It makes sense for researchers to study these variables together, because high cholesterol is associated with an increased risk of diabetes, which occurs when the body produces no insulin or insufficient insulin. However, before digging into the study, it’s important to know that cholesterol can be described as “good” or “bad.” “Bad cholesterol” refers to LDL (low-density lipoprotein), while “good cholesterol” indicates HDL (high-density lipoprotein), which helps remove LDL deposits. LDL (bad) cholesterol can accumulate inside your blood vessels, causing your arteries to become harder and narrower. Eventually, an artery can become so clogged that it gets completely blocked. When this happens, blood can no longer reach the tissue or organs on the other side of the obstruction, leading to a stroke or heart attack (myocardial infarction). This can occur whether you have diabetes or not, but diabetes patients are at an elevated risk for a number of reasons, including that diabetes has a tendency to decrease HDL levels while simultaneously raising LDL levels. The more LDL builds up in your arteries, the more likely you are to develop a blockage. In the Diabetes Care study, researchers examined 30 “chronic cannabis smokers” whose median self-reported use was six joints per day over a period of nine and a half years. (Participants’ use ranged anywhere from three to 30 joints per day, over a period of two to 38 years.) Slightly more than half of the participants – 18 out of 30 – were male. According to the study, “Cannabis smokers had lower plasma HDL cholesterol,” but unchanged levels of LDL. That means heavy daily cannabis users had a decrease in good cholesterol, but no increase ordecrease in bad cholesterol. However, a study published the year before in BMJ Open found a different result: that “marijuana users had a higher prevalence of serum HDL cholesterol [and] total cholesterol” – in other words, an elevated level of good cholesterol. The difference in findings is due partially to the fact that each study evaluated different bodily substances. The Diabetes study, which said that cannabis lowered good cholesterol while having no effect on bad cholesterol, examined participants’ blood plasma: yellow fluid that doesn’t contain any cells. The BMJ study, which came to the opposite conclusion, looked at participants’ blood serum: the part of your blood that remains after clotting occurs. Additionally, the cannabis use described in the Diabetes study was far heavier than the use described the BMJ study, which classified “heavy” use as more than five uses per month (as opposed to six joints per day). Another study, published in 2007 in Dialogues in Clinical Neuroscience, also examined marijuana’s effects on LDL and HDL. The Neuroscience study, while critical of cannabis as a potential (though rare) trigger for schizophrenia or psychosis, also noted an increase in good cholesterol in patients who used a drug called Rimonabant. Rimonabant actually blocks some of the effects of THC, but, like cannabis, acts on the brain’s CB1 receptors. Intended as an anti-obesity drug, Rimonabant was never approved for use in the United States because subjects reported feelings of depression and suicidal ideation. However, the fact that Rimonabant is a CB1 antagonist, like Cannabidiol (CBD), further suggests that medical marijuana could potentially have applications in helping to improve your cholesterol. Using Cannabis to Manage Your Weight Again, more research is needed with regard to the relationship between marijuana and cholesterol. While some studies have suggested that cannabis can raise your good cholesterol levels, others, like the one published in Diabetes Care, indicate the opposite effect. On the other hand, studies have shown that marijuana can help treat diabetes and reduce abdominal fat, so we know that cannabis can aid weight loss and enhance cardiovascular health – both keys to bringing bad cholesterol down. Of course, at the end of the day, the best and simplest way to control your weight and keep your heart healthy will always be proper diet and exercise. Fortunately, it’s quite possible to diet while using marijuana, as long as you follow some basic tips to control the munchies. If you’ve been diagnosed with diabetes, or are suffering from severe chronic joint pain or other complications due to your weight, medical cannabis may be able to help provide additional relief in conjunction with exercise, a healthy diet, and treatment with prescription medications. To talk about whether medical marijuana could be right for your cardiovascular condition, call Inhale MD at (617) 477-8886 today. https://lfpress.com/cannabis-health/cannabis-medical/can-using-cannabis-help-lower-my-cholesterol/wcm/cf5a1eba-a8b1-4e70-9f0d-215b53dede87 Bongme
  2. hi Check out our exclusive list of the top lawyers working on the biggest deals in the booming marijuana industry that's set to skyrocket to $194 billion globally With the rapid spread of marijuana legalization in the US, lawyers are discovering that the tangled web of regulations guiding the rapidly growing industry is a boon for business. After last year's midterm elections, some form of cannabis is now legal in 33 states, and many in the industry say it's only a matter of time before legalization sweeps the nation. Big money — and big law — has followed. The opportunity could be huge: some Wall Street analysts say marijuana could become an $80 billion market in the US alone in the next decade, with the global market hitting close to $200 billion. There are several key reasons lawyers are attracted to the marijuana industry. For one, as cannabis companies grow, merge, and start getting the attention of Fortune 500 corporations as acquisition targets, they need more sophisticated advice on financing, tax planning, corporate structure, and M&A. Publicly traded cannabis companies were on a dealmaking tear in 2019, scooping up competitors and signing multibillion-dollar tie-ups with pharmaceutical, alcohol, and tobacco corporations. It's a trend heating up this year. In addition, many marijuana companies still directly flout US federal law, despite being publicly traded and posting multibillion valuations. That's an opportunity to a select group of lawyers who have cut a trailblazing path into the industry. Once reluctant, some of the biggest law firms, like Duane Morris, Baker Botts and Dentons, are building out specialized cannabis practice groups as the industry continues to grow in profitability and complexity. And even some of the most world's most prestigious law firms, like Sullivan and Cromwell, have gotten in on the marijuana mergers-and-acquisitions action. Business Insider has pulled together a list of the top lawyers who've worked on the largest deals in the past year in the growing marijuana industry. https://www.businessinsider.com/exclusive-list-of-the-marijuana-industrys-top-lawyers-2019-1?r=UK&IR=T Bongme
  3. Hi What's coming up in soft drinks in 2019? - Predictions for the Year Ahead - Comment Over the coming weeks, just-drinks' category commentators will share with us their thoughts on how 2019 will shape their respective sectors. First up, Richard Corbett looks at the soft drinks and bottled water categories. As in previous years, soft drinks and bottled water can expect to face more than their fair share of challenges this year. While 2019 is unlikely to be a vintage year, globally, I would expect soft drinks consumption to rise by between 2% and 3% in volume terms on 2018. Soft drinks start to lose their bottle Soft drinks packaging will again be a flammable issue for the industry worldwide in 2019. In the UK, the term 'single-serve' became the Collins Dictionary word of the Year in 2018, highlighting just how quickly the debate on packaging has escalated in the public eye. This concern has been replicated in markets around the world. If you listen to some commentators, drinking out of a single-serve plastic bottle could one day be akin to turning up to the annual Vegan Society dinner dance in a fur coat. PepsiCo's deal to buy SodaStream, which closed in late last year, signalled the group's intention to take a lead on the issue of single-serve packaging. We can expect PepsiCo to be active in new product development with some potentially groundbreaking SodaStream developments later in the year. The Coca-Cola Co had been one step ahead of PepsiCo, but landed on a snake with Keurig Kold. I can foresee a major new announcement this year indicating a new direction for Coca-Cola's at-home dispense strategy. The industry may well look back on 2019 as the turning point for the way that consumers access their refreshment at home. Water in a carton? Bottled water already competes with existing 'home dispense systems' (the tap) so will need to seek other solutions to re-establish its green credentials. Ambitious longer-term plans to "take the single out of single-use" - in the words of Nestle - are admirable, but are not a short-term remedy. Conventional wisdom suggests that consumers like to drink their water from transparent containers, so they can be comfortable that there are no adulterations. In the Netherlands, however, the carton remains a popular format for still water sales, due to the deposit on bottles. The carton could be well-placed to take the sting out of the issue of plastic bottle use in still waters. If the carton companies get the message out, there will be plenty of listeners. The issue of plastic bottle use might also be expected to prompt a shift from plastic to carton in the premium juice segments where bottles are the packaging of choice for many suppliers. This could be aided by regulation: In Denmark, for instance, the Government announced plans last year to include plastic juice bottles in the deposit scheme with other soft drinks. Legal high for cannabis drinks? All eyes will be on Canada this year, as the drinks industry looks to monitor the progress of cannabis-infused drinks. Not surprisingly, the big alcohol players will be carefully assessing the consumer response to any new products that arrive on the market. So too will soft drinks operators. Coca-Cola has obviously caught a whiff of the opportunities for drinks infused with cannabis extract cannabidiol (CBD) but the group's PR team is understandably treading carefully. The official line is that Coca-Cola "doesn't have plans at this stage" to get involved. Anheuser-Busch InBev appears more convinced, closing 2018 with the creation of a big-money partnership with Canadian cannabis producer Tilray to research cannabis-infused non-alcoholic drinks. Reports of CBD's ability to provide pain relief and restrict inflammation could trigger the emergence of a huge new segment of the soft drinks market. Indeed, functional drinks that have a palpable health impact have proved to be highly lucrative. Just look at the effect on the market that Red Bull has had since its arrival around 30 years ago, or the explosion in probiotic drinks in the last decade or more. The marketing of any such product will not be a conventional one for a soft drink and nor will the route to market. I would expect products to start life in pharmaceutical chains to give them a sense of authenticity. Could there be a craft-style, backyard wellbeing cannabis-infused brand that emerges to steal the show? If drinks infused with CBD do prove to have a positive effect on pain relief, then any stigma associated with the links to cannabis will melt away - so will the regulations limiting its use in markets across the world. Coffee shops soften The rise of the coffee shop has been a key feature of the retail marketplace for some time now, but last summer's purchase by Coca-Cola of Costa highlighted how this fast-developing channel is very much on the radar for soft drinks players. I don't believe this is all about coffee. Consumers often buy their lunch in them, they meet in them and, as the rapid rise in northern Europe of the Joe & The Juice chain has shown, they don't just want to buy hot drinks in them. The coffee shop is becoming an important vehicle for soft drinks sales and that's why companies want a piece of the action as their outlet numbers swell across the world. Coffee shops also hold interest for soft drinks players because the range of soft drinks on offer is generally less conventional and more cosmopolitan than the mainstream. These outlets represent a chance to trial and test new, higher-end concepts on an audience that is more than willing to experiment with them - the coffee shop is often where the Millennial is found. UK headache for Fever-Tree Among investors, Fever Tree has gained celebrity status since its IPO launch back in 2014. The share price has ballooned from its opening GBP1.34, peaking at more than GBP40 back in September. Since then, however, the markets have soured and Fever-Tree has seen its price spiral downwards. 2019 will be an influential year for the company. I expect growth levels to be downgraded from stunning to good in the UK market this year. Even Usain Bolt slows after 200m and conditions in the summer of 2018 were very favourable to sales in the UK - a cooler summer this year would dampen demand. As a result, Fever-Tree will struggle to maintain its previous spectacular growth levels in what remains its core market. The focus, then, will switch to the US, where the company has moved many of its chips in recent times. This year, we'll be able to gauge more accurately the level of potential the brand really has. The US has more of a dark spirits culture, which could hamper development. Fever-Tree is fantastically well-marketed and has succeeded in relegating rival Schweppes into a B brand. For that reason, long-term success is a given. This year, however, we'll have more of an understanding of just how successful the brand will be. Ironically, a more modest year could prompt a more realistic market capitalisation, and even trigger an acquisition. https://www.just-drinks.com/comment/whats-coming-up-in-soft-drinks-in-2019-predictions-for-the-year-ahead-comment_id127505.aspx Bongme
  4. Hi Why Growing Your Own Cannabis Is the Best Resolution for 2019 Who grows the greatest cannabis on earth? You do, or at least you can, and it’s not as hard as you might think. But if 2019 is going to be the year you pop your first seeds or root your first cuttings, now’s the time to start planning and preparing for a spring planting. You can get started by reading Leafly’s two primers—one for those growing indoors and one for those growing outdoors. If, like most of us, you’re a hobbyist hoping to simply cover your yearly head stash, with plenty leftover to gift to friends, I’d definitely recommend starting outdoors, assuming you’ve got a suitable space to do so. Because depending on the climate where you live (including the legal climate), it’s pretty likely you can cultivate a few plants right next to your heirloom tomatoes or summer squash. Setting up indoors means figuring out everything from high-intensity lights to advanced hydroponics. Remember, we only started growing cannabis in basements and attics to avoid the cops. So let’s leave all that high-tech equipment to the professionals (and those still living under oppressive laws), and nurture your first-ever cannabis garden in your backyard—or side yard, or up on the roof, or wherever you’ve got a little space to work. Immediately, that takes an awful lot of the effort and expense out of the equation. And more importantly, small-batch sun-grown cannabis—cultivated in soil with organic nutrients—truly is the plant’s highest expression. But before we fully dig into how you will grow the greatest cannabis on earth in 2019, we need to start by asking why bother? I mean, if you haven’t heard, you can buy this stuff at a store now. But there’s still five good reasons you should take the means of cannabis production into your own hands this year. Value The most obvious reason to grow your own cannabis is that you can produce high-quality herb at a small fraction of what you’d pay at a dispensary, particularly once you factor in all of the taxes. For a rough estimate of return-on-investment, I asked my good friend and cannabis colleague Danny Danko, longtime cultivation editor at High Times magazine and author of the book Cannabis: A Beginner’s Guide to Growing Marijuana, for a run-down on the expected annual harvest for a six plant backyard garden, grown in soil with some basic organic fertilizer and plenty of sunshine. “Six small outdoor plants should yield 8-10 ounces of dried buds, so you’re looking at approximately 3 pounds total at the end of the season, and if you grow large outdoor plants, they could yield a pound or more each,” he says. Quality Okay, it may be a bit of hyperbole to say you will grow the best cannabis on earth, particularly your first year trying, but here’s a little secret: they call it weed for a reason. Cannabis is an incredibly hardy plant, and one that’s adaptable to a wide range of environments, so minus some kind of catastrophic event (spider mites, mold, thieving neighbors), you’ll almost certainly succeed in harvesting some truly lovely buds. How much and how lovely depends on your skill, your starting materials, and your diligence, but with just a few inexpensive inputs and some careful tending, you’ll most definitely be proud of what you produce. Because unlike large, bustling commercial operations, growing just a handful of plants per year allows you to give them the kind of individual tender-loving-care that will help them flourish from start to finish. And you can harvest at the absolute peak of potency and then treat your buds like the delicate, resin-coated flowers they are throughout the vital drying and curing process. You’d be surprised how much this improves the quality and potency of the finished product. Also, like a meal that you prepare yourself or children you raise from birth, some measure of the beauty of your buds will be in the eye of the beholder. Embrace that. Your dispensary (or dealer) may have the hottest new strains and the stankiest top-shelf brands on the market, but nobody else on earth can roll up a joint of your Backyard Kush or Basement Haze. Variety One of the biggest decisions you’ll get to make as a cannabis cultivator will be deciding which strain(s) to grow. Some people like to plant a uniform garden, so all the plants will mature at roughly the same rate and have roughly the same needs, while others want to try out as many different varietals as possible and see what works best. There’s no wrong answers, really, just keep in mind that your favorite strain to smoke may not be the best one to grow in your particular circumstances. Some cannabis strains grow short and stout and mature quickly (indicas), and some grow tall and wispy and take a long time to reach their peak (sativas). Certain strains have been bred to flourish outdoors and others are optimized for indoor growing. Some are highly resistant to wet weather and others mold easily. The quality of seeds and cuttings on the market also varies widely, so source only from reputable suppliers who stand behind their products and offer informed recommendations based on your detailed input. And then double check everything via Leafy’s comprehensive strain database. Connection If you truly love cannabis, what could be better than starting your day by watering a small collection of luscious herb plants while marveling at how quickly they grow? Gardening time is almost always quality time. And over time, you’ll become increasingly attuned to the life force of your plants and the heady milieu that envelopes your garden. Particularly as your cannabis becomes ever more fragrant towards the end of the season. Last year, six plants in 50-gallon containers sat right outside the door to my home office, and from mid-July until the day I cut them down, I didn’t walk past those plants once without taking in their fragrance. And let me tell you, that’s a unique and highly effective form of aromatherapy in a world gone mad. Decentralization Legalization is a many splendored thing. And obviously no adult, anywhere, should face criminal charges for growing, possessing, smoking, sharing, or selling this most wonderful plant. But legalization has also led to two troubling forms of consolidation. The first is a severe winnowing of genetic diversity in the cannabis gene pool caused by industrial agriculture sized cultivation facilities that focus on only a handful of strains that grow quickly and easily and have the most commercial appeal. The second form of consolidation happens when these hyper-capitalized companies begin to gobble up market share by either buying up their competition or pushing them to the margins through economy of scale. Both forms of consolidation represent existential threats to the cannabis plant and the cannabis movement as we’ve come to understand them. Rest assured, left to its own devices, “Big Marijuana” will do an excellent job of producing “mids”-quality Blue Dream in massive amounts at a low price point, but will do little to nothing to protect and preserve the incredible genetic diversity of strains that’s been created and curated by crafty cannabis breeders over the last half century. And meanwhile they’ll do everything they can to eliminate unwanted competition from the kind of small-scale Mom and Pop growers who’ve kept the plant alive and flourishing during the long dark days of prohibition. One way to push back on both forms of consolidation is to seek out cannabis from small scale traditional growers, particularly those specializing in rare and heirloom strains. But the best and most satisfying way is to become a small scale traditional grower who specializes in rare and heirloom strains—even if it’s just six plants per year. Take it from a guy who’s writing this article while casually puffing on some of his very own “proprietor’s reserve” buds from the 2018 harvest. https://www.leafly.com/news/growing/why-grow-your-own-cannabis-in-2019 Bongme
  5. Hi Maker of Budweiser is partnering with medical cannabis company Tilray in a $100m deal to research cannabis-infused drinks for Canadian market Daily Mail The maker of Budweiser is partnering with medical cannabis company Tilray in a $100 million deal to research cannabis-infused drinks for the Canadian market. The alliance announced on Wednesday is the latest foray by a major beer company into the cannabis business in Canada, which legalized recreational marijuana in October. Anheuser-Busch InBev and Tilray Inc. said each would invest $50 million in the project to study non-alcoholic drinks containing cannabidiol, or CBD, which some claim has calming and healing effects, and Tetrahydrocannabinol, or THC, the cannabis compound known for its psychoactive effects. Tilray had announced a day earlier that a subsidiary struck a deal with pharmaceutical company Sandoz AG to jointly operate in jurisdictions where cannabis is, or will be, approved for medical purposes. Tilray's shares jumped 15 per cent following news of the deal with AB InBev. Shares of AB InBev were little changed. Belgium-based AB InBev, the owner of more than 500 beer brands including Budweiser and Stella Artois, said it will participate in the project through its subsidiary Labatt Breweries of Canada. 'Labatt is committed to staying ahead of emerging consumer trends,' President Kyle Norrington said. British Columbia-based Tilray has products available in 12 countries and operations in Australia, New Zealand, Canada, Germany, Latin America and Portugal. Canada has emerged as a world leader in the cannabis industry, which is surging as legalization also expands in the United States. North American consumer spending on legal cannabis is expected to grow from $9.2 billion in 2017 to $47.3 billion in 2027, according to Arcview Market Research, a cannabis-focused investment firm. Earlier this month, Marlboro maker Altria Group Inc. invested $1.8 billion for a 45 percent stake in Cronos Group, a Canadian medical and recreational marijuana provider. In August, wine, liquor and beer company Constellation Brands announced a $4 billion investment in Canadian pot producer Canopy Growth Corp. Coca-Cola, Pepsi and Guinness brewer Diageo have said they are closely watching the market for cannabis as it evolves. https://www.dailymail.co.uk/news/article-6514039/Budweiser-maker-teams-Tilray-explore-pot-drinks.html 15 Comments at this time Top Hitter cootie, nyny, United States, I'd rather have a beer in one hand and a joint in the other. I like the psycho part. Bongme
  6. Hi Vid On Link Marijuana and CBD companies can't advertise on Facebook and Google, so they're getting creative David Bozin used to get cuts and scratches on his arms when it came time to bathe his golden retriever, Jax, who rebelled against the prospect of being dunked in water. Then he learned that dogs, like humans, respond to the properties of cannabidiol, also known as CBD, a cannabis compound that helps the body relax without producing intoxicating effects. Bozin got to work on a line of CBD-infused dog products, including a dry shampoo and puppy treats, that he calls ZenPup. But in trying to find customers for his new company, Bozin faces a unique challenge in today's market. He doesn't have access to Google , Facebook or Instagram (owned by Facebook), which have banned CBD and marijuana promotions. The two dominant online advertising platforms account for 57 percent of the U.S. digital ad market, according to eMarketer, and almost all emerging brands today count on Google's search ads and Facebook's precision targeting to efficiently get the word out. "Facebook is not the end all, be all. Instagram is not the end all, be all," Bozin told CNBC. "Does that mean you're not going to see as much traffic at the get go? Sure. But at the end of the day the most important point is conversion," or getting people to buy your products, he said. Marijuana is legal for recreational use in 10 states and Washington, D.C., and available for medical purposes in many others parts of the country. CBD is a bit more complicated because the laws are murky. Currently, 47 states allow some form of CBD sales. The 2018 Farm Bill, which Congress passed this week, allows states to decide if CBD products made from hemp can be sold in their jurisdiction. However, it doesn't protect the products from the Food and Drug Administration, which can penalize companies for making inaccurate health claims. "We avoid talking about anything too specific about what the product will do," said Cary Smith, senior vice president at agency North 6th Agency. "If you come from an educational standpoint, you skew towards less restrictions, and have a bit of a larger organic reach." With so much uncertainty in the market, Google and Facebook have shied away from allowing marijuana and CBD advertising, taking a similar approach to how they handle tobacco and related paraphernalia. When it comes to alcohol, Google prohibits companies from targeting underage users or promoting unsafe behavior, while alcohol advertising on Facebook has to adhere to local laws. In the absence of Google and Facebook, ZenPup has been forced to find alternative ways to launch its products. The co-founders, who worked in marketing and public relations, are spending time building relationships with media companies, high-end dispensaries and pet accessory retailers, along with other brands that might be open to partnering with a CBD provider. They're finding popular social media influencers, who can support the products organically on their accounts. ZenPup has also focused on clean, attractive packaging so that it's appealing for "shelfies," or staged product photos that people post on their feeds. "Those younger consumers are looking for something different from an aesthetic standpoint, that also is top quality and at a good price point," said Nicholas Weatherhead, ZenPup's chief marketing officer and co-founder. Connecting with your customers Other approaches are available to CBD companies, depending on the specific industry. Hillary Wirth, media director at the agency Noble People, said there are plenty of ways to get your brand in the right place. To promote Viceland's digital show "Weed Week," in April Noble People bought local and national TV ads with DirecTV and Comcast , as well as on channels like IFC , USA and BBC America, and focused on pornography site Pornhub. There are also digital ad networks like like Traffic Roots that allow marijuana and CBD ads. "So you can't advertise on Facebook or Google – it's not the end of the world," said Wirth. "There are plenty of other media channels that will get you contextually next to relevant weed content." Noble People got creative in other ways. The firm organized a Washington, D.C., Viceland event to allow people to "Smoke Weed with Jeff Sessions." But it wasn't the former attorney general — just a man from Wisconsin with the same name. https://uk.finance.yahoo.com/news/marijuana-cbd-companies-apos-t-191100796.html Bongme
  7. hi Pepsi shoots down rumors that it is considering cannabis following a report that Coca-Cola is eyeing CBD-infused beverages PepsiCo has no plans to enter into the cannabis business, the company said in a call with investors on Tuesday. Insiders have been buzzing about Pepsi's potential interest in CBD-infused beverages or snacks, following a report that Coca-Cola is eyeing a deal with marijuana producer Aurora Cannabis. CBD is already a $1 billion business, and analysts say that CBD-infused beverages could become a huge new category, similar to energy drinks. Insiders have been buzzing about PepsiCo considering a move into the cannabis business, following a report that Coca-Cola is eyeing a deal with marijuana producer Aurora Cannabis. However, on Tuesday, the snack-and-beverage giant shot down the rumors during a call with investors. Hugh Johnson, PepsiCo's CFO, said in response to a question on cannabis-infused products that the company looks at everything, but has no plans at this point to enter into the market, due in part to regulatory issues. In late September, analysts said that they saw Coca-Cola's reported interest in CBD as not too surprising, as CBD-infused drinks could be a boon for the beverage giant. CBD is already a booming, $1 billion business, and it is being used as an ingredient in salves, oils, balms, and beverages, despite continuing legal questions. Beverage giants investing in CBD-infused drinks could result in the creation of a new mainstream category of beverage. A deal between Coca-Cola and Aurora Cannabis could "broaden the reach of cannabis-­infused beverages into functional wellness categories, enabling KO to potentially one day 'own' the non­recreational cannabis-­infused beverage category," Wells Fargo analyst Bonnie Herzog wrote in a note to investors. With the potential of a new category looming, news of PepsiCo's interest in the industry seemed likely to follow. Vivien Azer, an analyst at Cowen, said in a note to clients in late September that she "would not be surprised" to hear of a deal between PepsiCo and a cannabis company, proposing that a CBD brand could serve as a "good complement" to PepsiCo's Gatorade franchise. However, it seems PepsiCo isn't ready to officially signal interest in CBD or cannabis — at least, not yet. Cannabis stocks have been booming, to a degree that has raised concerns among certain investors. Regulation remains murky, and CBD's actual impact is still unknown. "The question is: Is it going to be something akin to energy drinks — a new category that is trendy at first, that actually grows into a meaningful long-term business? Or is it going to be sort of a fad?" Duane Stanford, the executive editor of industry publication Beverage Digest, told Business Insider. http://uk.businessinsider.com/pepsi-shoots-down-cannabis-deal-rumors-2018-10 Bongme
  8. Hi Kids pick up marijuana at younger age if their mothers use the drug, Harvard study finds Daily Mail When mom uses marijuana, kids are more likely to try the drug at a younger age, a new study shows. When mothers used cannabis during the first 12 years of a child's life, there was a 40 percent higher likelihood the kid would start using the drug earlier than peers whose moms weren't using, researchers reported in the American Journal of Preventive Medicine. On average, children whose mothers used marijuana tried it themselves an average of two years earlier than peers whose mothers didn't use the drug. That puts those kids at risk for a host of marijuana-linked problems, said lead study author Natasha Sokol, who was a doctoral student at the Harvard T.H. Chan School of Public Health when the research was done. Kids with mothers who used marijuana were at increased risk of starting to use the drug themselves before age 17. Their peers were more likely to start at 18. The time between 16 and 18 'is a critical period of development,' said Sokol, who is now at the Center for Alcohol and Addiction Studies at the Brown University School of Public Health. 'Marijuana might be disrupting certain aspects of brain development, including the development of the endocannabinoid system. It's been associated with depression and, in predisposed individuals, there seems to be an increased risk of the development of psychosis.' Marijuana use at this age can also affect a child's ability learn, Sokol said. 'Missing school or functioning at a lower level in school is a big deal,' she said. 'Especially if it's for an extended period of time.' Sokol and colleagues analyzed data from participants in the National Longitudinal Survey of Youth and their biological children who signed on for the NLSY Child and Young Adults survey. The NLSY is a nationally representative survey that included 12,686 individuals living in the U.S. in 1979 between the ages of 14 and 21. NLSY participants were interviewed annually up until 1994 and then biennially after that. Out of 4,440 mother-child pairs identified by the researchers, 2,983 children, or 67 percent, and 1,053 moms, or 35 percent, said they used marijuana. One limitation of the study, Sokol said, is the researchers didn't have information on whether the kids knew their moms were using cannabis. While that is a limitation of the study, 'we also know that children are much more aware than we think they are,' said Dr. Michael Lynch, a toxicologist and emergency medicine physician and medical director of the Pittsburgh Poison Center at the University of Pittsburgh Medical Center. 'That's been proven again and again.' Lynch said he wasn't surprised to see children imitating behaviors modeled by their parents. But, 'it's nice to have a peer-reviewed work that identifies the risk that children are more likely to start using marijuana if they grow up in homes with a mother who uses the drug,' he added. The findings are 'concerning' Lynch said. 'That's because it's in the context of expanding use and a more permissive culture around marijuana use,' he added. 'All - even proponents - agree that younger initiation is unhealthy. That's been fairly well studied, from an academic and career standpoint and from a cognitive development standpoint.' Moreover, Lynch said, people who start marijuana at a younger age are at greater risk of addiction to either marijuana or prescription opioids. 'The finding is important but not surprising,' said Dr. Salomeh Keyhani, a professor of medicine at the University of California, San Francisco. 'Studies of maternal tobacco smoking and adolescent initiation have had similar findings.' 'The results are particularly concerning given the unresolved debate on the association of adolescent use of cannabis and decreases in IQ,' Keyhani said. 'The results are also concerning because there is no coordinated public health campaign that is informing the public of the potential risks of cannabis use.' Sokol hopes her new findings won't be misused. 'I don't think this study needs to be evidence against legalization,' she said. 'That's not a successful public health policy.' https://www.dailymail.co.uk/health/article-6203545/Kids-pick-marijuana-younger-age-mothers-use-drug-study-finds.html 57 comments Top Hitter mama_mia, St. James, Barbados If marijuana was the only drug I had to worry about with my two teenagers, I would be happy. Bongme
  9. Hi Tea Break news Does Coca-Cola think it's high time for cannabis coke? Company 'close' to joint venture to sell drinks infused with marijuana Daily Mail Coca-Cola is said to be close to a deal that could see it infuse cans of soft drink with cannabis. The US giant is said to be in 'serious' discussions with a cannabis producer as it looks to grab a slice of the burgeoning marijuana market. A deal with the firm, Aurora Cannabis, could lead to Coca-Cola selling drinks infused with marijuana, which is said to have health benefits such as easing inflammation, pain and cramping. The conglomerate is likely to use cannabidiol, known as CBD, to develop the drinks. CBD is the non-psychoactive ingredient found in cannabis that is said to help ease pain but without the buzz or high some users seek. According to US-based Bloomberg news, sources close to negotiations said Coca-Cola and Aurora are 'pretty advanced down the path' of doing a deal. 'It's going to be more of a recovery drink,' the source added. If Coca-Cola seals a contract with Aurora it would be the first major soft drinks firm to make a move into the marijuana market. Canada is set to legalise the recreational use of cannabis next month as more states across the US make it legal. CBD oil is already on the shelves in the UK and is increasingly popular among those seeking an alternative to aid sleep and alleviate mental health conditions such as depression and anxiety. However, it can only be sold as a food supplement. In 2016, the Medicines and Healthcare products Regulatory Agency said items containing CBD would have to be licensed if they were advertised for medical purposes. A spokesman for Coca-Cola refused to comment on speculation but added: 'Along with many others in the beverage industry, we are closely watching the growth of non-psychoactive CBD as an ingredient in functional wellness beverages around the world. 'The space is evolving quickly. No decisions have been made at this time.' A spokesman for Aurora, which is based in Canada, said: 'Aurora has expressed specific interest in the infused beverage space, and we intend to enter that market.' There are growing calls for a separate type of oil derived from cannabis that contains THC, the psychoactive ingredient of the plant, to be more widely available. Home Secretary Sajid Javid announced in June that doctors in the UK would be able to legally prescribe cannabis-derived medicinal products under strict conditions. It followed the cases of Alfie Dingley, six, of Kenilworth, Warwickshire, and Billy Caldwell, 12, from County Tyrone, Northern Ireland, who were given temporary licences for the oil to treat their severe epileptic seizures. The boys were originally denied the oil after it was confiscated at border control. Mr Javid stressed it was not a move towards the legalisation of cannabis, which is currently a controlled drug. https://www.dailymail.co.uk/news/article-6176903/Coca-Cola-talks-produce-marijuana-infused-drinks.html 518 Comments Top Hitter JeremyOsborne, Richmond Upon Thames London , United Kingdom We love you Coca-Cola Bongme
  10. hi Vaping Weed Safer than Smoking Cigs Vaping cannabis seems to have even fewer health risks than smoking it As rational, health-conscious men, we should avoid behaviors that likely will cause harm even under the best of circumstances. Certain sports and physical activities may cause harm, but with proper training and equipment, these risks can be minimized if not completely eliminated. Smoking, on the other hand, is detrimental to our health. At least, smoking tobacco is. What about smoking other things, or vaping instead? Even tobacco company Reynolds American Inc. admits that These diseases and others can show up after years without smoking. My father died of chronic obstructive pulmonary disease, though he stopped smoking decades before. For smokers worried about their health, Reynolds adds, “The best course of action … is to quit.” Anything that can decrease or eliminate smoking sounds like a positive development. Vaping may be just the ticket. Though cannabis—marijuana if you prefer—can be smoked like tobacco (or mixed with tobacco), that’s not the only way to experience it. Vaporizers—such as a vape pen—heat but don’t burn the weed, producing an aerosol (vapor) with fewer carcinogens and lung irritants. They, however, are too new to conclude that they are entirely risk-free. Not that all noncombustible products are created equal. There are important differences between devices, the materials from which they are made and the forms of products put into them. A so-called e-liquid containing nicotine is most common. A Johns Hopkins study detected the presence of potentially dangerous elements, including lead and arsenic, in e-cigarette liquids, with much higher quantities in vaping pens with fresh metal heating coils. Some have ceramic heating coils, others quartz, both of which seem to release less or no lead and arsenic. Cancer and other diseases aren’t the only problems with nicotine. It also is addictive. Cancer Research UK states that “Nicotine causes addiction in much the same way as heroin or cocaine and it is just as addictive as these ‘harder’ drugs.” Marijuana, according to the best science, has less risk of addiction, maybe mostly psychologically. E-cigarettes and vaping pens can function as nicotine replacement therapy (NRT), reducing the risk of smoking-related diseases, just as methadone or buprenorphine (Suboxone) can function as medication-assisted treatment (MAT) in heroin rehab programs. Whether smoking or vaping marijuana has the same or similar health risks isn’t asked very often, even by marijuana opponents. (They tend to focus on whether or not cannabis is addictive, and if so, how much.) Maybe that’s because they know they won’t like the answer. Though cannabis research is limited—in size and number, by the inability to get legal, government-grown marijuana for study—most studies conclude there is little or no risk of cancer associated with smoking marijuana, particularly when compared with tobacco. Although marijuana smoke does have many of the same carcinogens as tobacco smoke, it seems cannabis also has some cancer-retarding properties that may reduce or eliminate the risks. That doesn’t mean there may not be other, significant lung health risks short of cancer. Vaping cannabis seems to have even fewer health risks than smoking it, though again there is not enough evidence to say there is no risk. Since there’s a chance that it may cause harm, it would be more responsible, more grown up, to not smoke or vape anything. That’s the problem. Smoking is adolescent. Almost no one starts smoking as an adult. Nicotine is so incredibly addictive, however, that once you start it is very difficult to quit. To paraphrase the Jesuits and Muriel Spark, “Give me a child at an impressionable age and they are mine for life.” Likewise, marijuana may do long-term damage to the developing teen-aged brain that it doesn’t to the adult brain. The way it looks right now, vaping tobacco is less harmful than smoking it since the combustion releases more carcinogens and the smoke irritates the lungs more than the vapor. Marijuana seems (to all but the most rabid anti-grass zealots) to be less harmful than vaping tobacco, and vaping marijuana is safer still. Another argument in favor of cannabis: Although tobacco has no currently accepted or rationally argued health benefits, the same is not true of marijuana. Many US politicians and some physicians say that marijuana has no proven benefits either, but that, again, maybe because it is too difficult to get permission to test it. Meanwhile, there are many people who testify to the health benefits of cannabis for anxiety, post-traumatic stress disorder, chronic pain management and even withdrawal from deadly opioid drugs. Say what you like about marijuana, there is not a single documented case of anyone dying from an overdose of marijuana, despite many legalization and decriminalization opponents looking for one. It seems to be physically impossible. Although marijuana is illegal at the federal level, 60 percent of the US population thinks it should be legal, recreational as well as medical, and about the same percentage of states have passed ballot measures or laws making it so under their laws. The US tried Prohibition for alcohol, which was and is a health hazard, but it didn’t work. Many people decided they’d rather break the law than stop drinking. All that was accomplished was the creation of a vast criminal apparatus to feed that desire. The crackdown on marijuana, heroin, and opioid prescription painkillers has had a similar effect, leading to drug cartels, crime, overdose deaths, and violence. Not so curiously, in states where recreational marijuana has been legalized, the amount of crime, violence and overdose deaths has decreased. The same is true of areas where safe injection sites have been established, where addicts can test their drugs to make sure they’re getting what they paid for (some prescription painkillers are counterfeits, using cheaper, easier to find, but much stronger opioids such as fentanyl), clean needles and medical assistance if needed. Vaping marijuana is not a monolith either, and while there is little research about the safety or dangers of vaping, some methods may be safer than others. First, there’s the hardware, from a hand-held bong or water pipe to a vape pen. They come in different materials, too, which may or may not affect the release of carcinogens. The most common form of cannabis for vaping pens is a concentrate known as butane hash oil (BHO), typically made by pouring lighter fluid through poor-quality pot and filtering it. Other vaporizers use loose pot, whole bud or ground, with heated water. There’s even a Keurig-style cannabis device using pre-filled pods that may come to market soon. If vaping appears to be the safest way of using tobacco and marijuana, in the interests of harm reduction we should encourage users to switch. Some people may continue using longer than they otherwise would have, but fewer people will die. That seems a fair trade-off. https://goodmenproject.com/featured-content/vaping-weed-safer-than-smoking-cigs-ndgt/ Bongme
  11. hi 5 things to know about cannabis, according to UW pharmacist profs Effects of marijuana can be pleasant, unpleasant or medicinal, says pharmacy prof A team of pharmacists at the University of Waterloo released a new video telling people the five basic things they need to know about cannabis. The video is narrated by professor Michael Beazely, who gives the audience an idea of what using pot feels like and how long the effects can last. "Like with any drugs, there are pleasurable effects, in some cases, there are medicinal effects and there are adverse affects," said Beazely on CBC K-W's The Morning Edition. Beazely said the video was produced by his colleague, professor Kelly Grindrod. "This had a clear goal, it was ... to really give five basic points about cannabis for health professionals, for pharmacists, but in this case, the video works well for everyone," he said. 1. The affects of cannabis can vary. The well known components are tetrahydrocannabinol (THC) or cannabidiol (CBD). THC makes people feel high and can cause hunger, sleepiness, paranoia and anxiety. CBD doesn't get people high and is believed to be more medicinal. The amounts of THC or CBD can vary in different strains. 2. There is emerging evidence that cannabis can be used for chronic nerve pain, palliative care, nausea and vomiting from chemotherapy, spasticity from multiple sclerosis and certain drug-resistant seizure disorders in children. 3. For every hundred people who use cannabis, many will feel high, sleepy or dizzy. Ten to 20 people will have muscle twitching, low blood pressure or feel intensely happy or uneasy. Five to 10 people will experience cannabis use disorder or memory trouble and up to five people will have acute psychosis or dissociation. 4. Inhaled cannabis starts working in minutes and last around four hours. Edible products start working around in an hour or more, lasts around six hours in adults and 12 hours in kids. 5. Cannabis should be avoided in pregnancy, breastfeeding and when there is a personal or family history of psychosis. It can double the risk of psychosis in young people, especially if a sibling or parent has a psychiatric disorder. In addition, Beazely said driving and using heavy machinery should be avoided after consuming cannabis, as it can impair motor function and coordination. It should also be kept out reach of children to prevent accidental poisoning. "Whenever possible, avoid smoking cannabis. Vaping and edibles are thought to be safer," he said. https://www.cbc.ca/news/canada/kitchener-waterloo/uw-5-things-to-know-cannabis-1.4812744 Audio and Vid On Link Bongme
  12. Hi Summer Got You Feeling Stressed? Cannabis May Help A study from 2009 indicated that Cannabis was used for relaxation, stress relief and anxiety reduction, while statistics for women users were around 10% higher Relaxation is the most widely cited reason why people consume cannabis. (According to 55 percent of respondents polled in a 2009 study) Cannabis has been considered a stress reliever for nearly half a millennia and modern science has verified that this treatment works. Not only has research confirmed the efficacy of the medical marijuana, more and more Americans are treating stress-related conditions with the herb. Marijuna for Relaxation According to a study published in 2009 in the Journal of Substance Abuse Treatment, findings suggest that cannabis is commonly used as a stress-coping strategy. Additionally, New Frontier Data, a cannabis data analysis firm, conducted a study last year and revealed: Relaxation (55 percent) is the most widely cited reason why people consume cannabis. The next three most common reasons cited are to relieve stress (40 percent), to enhance the enjoyment of a social experience (40 percent) and to reduce anxiety (39 percent). Women are significantly more likely than men to consume cannabis to relieve stress (+7%) and to reduce anxiety (+13) Relaxation and stress relief are overwhelmingly the most commonly perceived benefits of cannabis use, according to the UK’s Independent Drug Monitoring Unit. And a Yahoo News and Marist College survey found that of the 35 million adults in America using marijuana, 37 percent say they turned to marijuana for relaxation. A History Lesson During the Age of Discovery, physicians and clergymen pioneered the modern use of cannabis as a treatment for stress. In 1621, English clergyman Robert Burton endorsed cannabis for the treatment of depression. And In 1860, the Ohio State Medical Committee on Cannabis concluded: “As a calmative and hypnotic, in all forms of nervous inquietude and cerebral excitement, [cannabis] will be found an invaluable agent, as it produces none of those functional derangements or sequences that render many of the more customary remedies objectionable.” Washington State University at the Forefront As marijuana legalization spreads across the nation – and around the globe – new research demonstrates that these previous cultures were onto something. And scientists from Washington State University are among the leaders in this research. In a first-of-a-kind study earlier this year, Washington State University scientists examined how peoples’ self-reported levels of stress, anxiety and depression were affected by ingesting different quantities and types of cannabis. Their work, published in the Journal of Affective Disorders, reveals that cannabis can significantly reduce short-term levels of depression, anxiety. The study marks one of the first efforts by American scientists to examine how cannabis with varying amounts of tetrahydrocannabinol (THC) and cannabidiol (CBD) affect consumers’ feelings of well-being when consumed outside of a research lab. “Existing research on the effects of cannabis on depression, anxiety and stress are very rare and have almost exclusively been done with orally administered THC pills in a laboratory,” according to Carrie Cuttler, clinical assistant professor of psychology at WSU and lead author of the study. “What is unique about our study is that we looked at actual inhaled cannabis by medical marijuana patients who were using it in the comfort of their own homes as opposed to a laboratory.” Entourage Effect: THC and CBD Work Best Together The WSU researchers discovered that one puff of cannabis high in CBD and low in THC was optimal for reducing symptoms of depression. Two puffs of any type of cannabis reduced symptoms of anxiety. Ten or more puffs of cannabis high in CBD and high in THC produced the largest reductions in stress. “A lot of consumers seem to be under the false assumption that more THC is always better,” Cuttler told Science Daily. “Our study shows that CBD is also a very important ingredient in cannabis and may augment some of the positive effects of THC.” (The synergistic effect of CBD and THC working together is known as the Entourage Effect). Cannabis for Anxiety Reduction The researchers also found that while both genders reported decreases in all three symptoms after using cannabis, women reported a significantly greater reduction in anxiety following cannabis use. Greenlight Approved is a consumer education platform dedicated to “guiding the cannabis curious.” We believe when you start something new, it’s best to start slow. Gather all the information you can to make a safe informed decision. Let Greenlight Approved be your guide so your first experience with cannabis is an educated, safe and positive one. Let us be your resource and guide to participating retailers near you, at www.greenlightapproved.com. http://www.spokesman.com/stories/2018/jul/29/summer-got-you-feeling-stressed-cannabis-may-help/ Bongme
  13. hi Can Legal Cannabis Help Slow the Opioid Drug Epidemic in the U.S.? Imagine stopping 115 needless deaths in the U.S. every day. It's not a guarantee, but with recent developments in cannabis research, experts believe it could be on the horizon. Opioid drug overdoses claim those 115 lives every day in this country. About 60% of opioid addictions are rooted in prescription drug use for a number of ailments, ranging from chronic pain to sports-related injuries to personality disorders. That's where many see cannabis products coming in to help. Read More About Investing In Cannabis Via Real Money "One-hundred fifteen people die every day as a result of opiates nationwide. So from our vantage point, we think cannabis is a sensible solve to a lot of issues," said Acreage Holdings CEO Kevin Murphy. "I believe it's going to be the silver bullet over the next 20 to 30 years as it relates to medical." According to the National Institute on Drug Abuse, 21% to 29% of patients prescribed opioids for chronic pain misuse them. Between 8% and 12% develop an opioid use disorder. Opioid overdoses increased 30% from July 2016 through September 2017. But while the opioid epidemic picked up both momentum and national attention, so too did the spread of regulated medical-use marijuana. Medical cannabis is currently legal in 30 states in the U.S., and has been legal across Canada since 1999. In a 2016 study by Dr. Dustin Sulak, 39% of opioid users who began using cannabis were able to completely stop opioid use and another 39% could reduce their opioid dosage. Sulak found that adding cannabis reduced pain by about 40% in nearly half the treated patients and improved function in 80% of them. "As an effective treatment for chronic pain, it can stop opiod addiction before it occurs," said Dr. Sherry Yafai, medical director of High Sobriety in Los Angeles. Cannabidiol, or CBD, is one of at least 113 cannabinoids found in the cannabis plant. It'a not to be confused with tetrahydrocannabinol, or THC, the cannabinoid in the plant with psychoactive effects. CBD is largely thought to maintain properties of healing and pain relief. But despite the anecdotal evidence from the likes of celebrities and viral social media apostles of the healing qualities of cannabis plants (see Kiss rocker Gene Simmons talk cannabis with TheStreet below), medical experts say there needs to be more research before cannabis can be billed as the solution to the opioid epidemic. For one, the cannabis plant is a complex one. Research professionals haven't yet identified all of the many, many compounds within the plant and how each may contribute to modern medicine. There's reason to believe CBD and THC, taken separately and together, can help with opioid treatment, withdrawal symptoms and pain management. As far as opioid use is concerned, cannabis compounds can enhance pain relief and other medical effects of opioid drugs. Taking cannabis with opioids also widens the therapeutic window, or the time between an effective dose of opioids and a lethal dose, Dr. Sulak said. But perhaps the biggest benefit of cannabis as a part of opioid treatment is that it doesn't carry the risk of overdose. https://www.thestreet.com/lifestyle/can-legal-cannabis-help-slow-the-opioid-drug-epidemic-14613856 Bongme
  14. Hi Published on 9 Jun 2018 TNMNews.com | Marijuana News, Cannabis Culture, Investing Bongme
  15. hi More Women Are Talking To Their Kids About Cannabis, & Experts Say That's Actually Good Almost half of mothers would prefer that their kids dabble with marijuana than alcohol, so more women are talking to their children about cannabis, according to a new study. The women surveyed in the study reportedly feel like they're stigmatized for their use of cannabis, but they're not alone in having conversations with their children about it. These conversations include everything from how to safely consume recreational cannabis to its medical benefits, according to the Georgia Straight, Canada's largest urban weekly. The study was conducted by Van der Pop, a cannabis blog and lifestyle brand. It found that 70 percent of the more than 1,500 North American women polled feel like they're criticized by friends, family, and colleagues for using cannabis, but 89 percent of women said they are talking to their children about cannabis anyway, the Georgia Straight reported. But they're not talking about it telling their kids not to try it — there's less cannabis shaming and warning, and there's a lot more pro-cannabis talk. Using marijuana during adolescence could have a long-term impact on a teen's memory, problem-solving skills, and critical thinking, according to CNN. But while many parents are therefore adviseaczxcd to talk to their kids about what they might lose if they use marijuana during their teenage years, evermore are talking to their kids about how to safely consume it and about its health benefits. Many kids are going to try it at some point anyway, according to Very Well Mind. Among those aged 18 or older who reported lifetime marijuana use, almost 53 percent reported first using marijuana between the ages 12 and 17 — and about two percent reported that they first used marijuana before age 12. Twenty-nine states and the District of Columbia now have laws that legalize marijuana in some form. And the legality of marijuana use seems to have affected how kids perceive cannabis. The American Academy of Pediatrics recently issued new guidelines for doctors and parents to talk to teens about the risks of using marijuana because changes in the legal status of marijuana may lower teen perceptions of the risks, the organization said in a statement. In fact, the National Survey on Drug Use and Health found a decrease in the percentage of 12- to 17-year-olds who said they believe there is a "great risk" in smoking marijuana once a month or one to two times per week. So women might as well be open with their kids about usage. We already know that mothers are more lax about marijuana use these days. More pregnant are smoking pot, according to a study published in the Journal of the American Medical Association. Among pregnant women 18 to 24, 9.8 percent smoked pot in 2009 and 19 percent smoked pot in 2016. While the increase in marijuana use for older age groups was still evident, it wasn't as steep; it rose from 3.4 percent to 5.1 percent among women 25 to 34 years old and from 2.1 percent to 3.3 percent among women older than 34. And 38 percent of parents in the recent Van der Pop also added that they feel like cannabis helps them be more playful and patient as parents. "Cannabis is not the enemy anymore, the way it was when I was growing up," April Pride, founder and CCO of Van der Pop (and mother herself) reportedly told the Georgia Straight. "Parents are closer to their kids and they have a much more transparent relationship surrounding cannabis." The more open parent-child relationships are, the safer children will be; so maybe more moms should be having "the weed talk" with their kids —without scaring them. Vid On Link Bongme
  16. hi Cannabis lounges not limited to Amsterdam anymore. Now, even California has them! On Link To much cut and paste... https://economictimes.indiatimes.com/the-new-amsterdam/slideshow/63313387.cms Bongme
  17. Hi 6 International Cannabis Strains Worth Seeking Abroad Travel is like cannabis; it broadens your perspectives…personally, culturally, and politically,” according to bestselling guidebook author and acclaimed PBS host Rick Steves. “Suddenly, the palette with which we paint the story of our lives has more colors.” For a cannabis enthusiast, this idea of expanding our palettes rings especially true, because even in our current heady era of rapidly advancing legalization, many of the world’s finest and most exotic cannabis strains can only be found in their regions of origin. So if we think of each varietal of the plant as its own unique hue, then we must travel widely to truly experience the species in all its technicolored glory. Much as your local liquor store carries wine and beer from around the world, we should be able to sample the finest cannabis available anywhere without leaving home. Another way to look at this is as an opportunity to get out and do some exploring. As a longtime cannabis journalist, I’ve had the good fortune to travel widely in parts of the world where the love of this plant flourishes, and I can report back that each place comes complete with a particular cannabis strain that’s a point of local pride. Some among the finest I’ve ever sampled. So what are we waiting for? Origin: Barcelona, Spain Much like the coffeeshops in the Netherlands, the cannabis social clubs that have cropped up in Barcelona and elsewhere in Spain over the last decade aren’t really legal, they’re just tolerated—for the most part. Clubs have been busted by the authorities in the past, and the Spanish legal system is still grappling with how to enforce (or not) a set of cannabis laws that allow for “personal” consumption in a “private” setting, without ever defining those terms. The city itself, of course, is one of the world’s ideal places to be stoned. Tapas is the ultimate stoner cuisine, and Gaudi is the best architect ever when you’re high. The most popular local strain when I was there some years ago was Jack Herer, an American-bred varietal that most assuredly flourishes beneath a Spanish sun. But to experience a truly homegrown phenomenon, take the time to track down Cannatonic, a high-CBD strain bred by Spanish seed bank Resin Seeds. With THC rarely above 7% and CBD potentially above 15%, it’s a cross of MK Ultra and G13 Haze with a “slight earthy odor and a mild, sweet, vaguely citrusy flavor.” While not providing much of a high due to its elevated CBD profile, the strain offers profound therapeutic relief for pain, inflammation, and anxiety. It’s the perfect way to unwind after a long hot day wandering La Rambla. Dr. Grinspoon Origin: Amsterdam, Netherlands As a travel destination, Amsterdam offers up many charms, from the picturesque canals and lively nightlife to the parks and museums and a place called Febo, where you can buy deep fried cheese out of a coin-operated automat in the middle of the night. The city’s also been a refuge for cannabis consumers and cannabis itself for decades. Not only have Amsterdam’s famed coffeeshops attracted visitors from around the world since they opened in the 1970s, they’ve also served as a safe haven for cannabis strains from every continent to escape prohibition. If you’re fortunate enough to make a visit, definitely sample some Neville’s Haze or any of its Haze cousins, and don’t miss out on the wide array of imported, traditionally made hashishes available from Morocco, Nepal, Afghanistan, and other distant lands. But if I had to recommend just one smoke in town, I’d say make an appointment with Dr. Grinspoon, a pure sativa heirloom strain bred by Barney’s Farm, a cannabis seed bank associated with one of Amsterdam’s top coffeeshops. Like all purebred sativas, the strain (named for medical cannabis advocate Dr. Lester Grinspoon) takes a long time to harvest and doesn’t yield very well—but who cares? You’re not growing it, you’re smoking it. And the soaring, cerebral, invigorating high will set you off on an adventure to remember (or forget) in one of the world’s most beautiful cities. Lamb’s Bread Origin: Jamaica Jamaica has long been associated with ganja, a local word for cannabis that derives from an ancient Sanskrit word that reached the Caribbean in the mid 1800s, brought along by indentured servants freshly arrived from India. In time ganja spread to native born Jamaicans. In particular, the Indians’ use of cannabis as a spiritual sacrament would be adopted by Jamaica’s Rastafarian community. Add in the global impact of reggae music, and the indelible idea of Jamaica as a cannabis paradise took root in the public’s imagination. Even though, until recently, cannabis remained highly illegal and the laws against it seriously enforced. Happily, however, that all began to change in 2015, when a new law decriminalized up to two ounces of cannabis and made personal grows legal. So how best to celebrate if you happen to be lucky enough to make a pilgrimage? Well, nothing could be more appropriate than rolling up a joint of Lamb’s Bread—the definitive Jamaican cannabis strain, and purportedly Bob Marley’s favorite throughout his life. A bright, green, sticky heirloom sativa, it’s an uplifting, inspiring, energizing high that pairs nicely with a cup of local Blue Mountain coffee if you really want to get your day started right. Origin: Malawi Revered as a food, fiber, and medicine, cannabis flourished throughout Malawi until 1964, when the newly independent republic joined the United Nations and adopted the UN’s Single Convention on Narcotic Drugs. Fifty years of mandated federal enforcement later, what the locals call chumba, and the world calls Malawi Gold, remains a vital cash crop throughout the impoverished African nation, but growers now plant their seeds in remote mountain clearings, hoping to elude the authorities. According to a 2011 report from the World Bank, Malawian farmers harvest around 150,000 pounds of remarkably potent cannabis in this manner every year, the vast majority bound for Europe. The plant remains illicit to this day, but there’s a strong movement in Malawi to legalize both cannabis and hemp. Famous throughout Africa for its potency, Malawi Gold is a pure sativa strain that’s slow to mature, with a flowering time of up to 120 days before it’s ready to harvest. But it’s worth the wait to smoke the long, resin-coated buds that have made the strain famous far beyond Malawi’s borders. Cheese Origin: United Kingdom Britain’s cannabis scene isn’t well known for producing high quality cannabis or award-winning strains, with one notable exception. An indica-dominant hybrid named for its sharply sour aroma, Cheese has been the herbal pride of the United Kingdom since the late 1980s. Local legend has it the original Cheese (sometimes called Original Cheese) descended from a Skunk #1 phenotype that was selected for future breeding based on its incredibly pungent aroma. The most popular modern version comes from Big Buddha Seeds, and features the same pungent funky aroma plus the addition of Afghani indica genetics to increase trichome production and yield. Big Buddha’s version put Cheese on the global map when it took home top honors in the Sativa category at the 2006 Cannabis Cup and has been spreading out geographically ever since. But it’s still best enjoyed at home, in Merry Old England, paired with a cup of Earl Grey and some tasty crumpets. Island Sweet Skunk Origin: Vancouver Island British Colombia—Canada’s westernmost province—stretches from the ocean to the Rocky Mountains. The region became a hotbed for cannabis cultivation starting back in the 1960s, when the ranks of the area’s homegrown farmers were swelled by the arrival of draft resisters from the US who began fleeing to Canada to avoid service in the Vietnam War. With its capital city of Vancouver eventually earning the nickname Vansterdam for its tolerance of cannabis coffeeshops, and the entire province boasting vast stretches of remote land in which to grow cannabis, a culture of tolerance and acceptance took hold in BC even in the darkest days of Canada’s cannabis prohibition. And now that it’s legal nationwide, British Colombia remains the ultimate Canadian cannabis travel destination, a place of natural beauty and vibrant culture. Island Sweet Skunk was originally bred on Vancouver Island, a 290-mile long, largely undeveloped stretch of coastlines and mountains just off the Pacific coast. A sativa with an electric buzz and a flavor profile that mixes classic skunky notes with ripe grapefruit undertones, the strain is a descendant of Skunk #1 and grows tall, straight, high-yielding plants. https://www.leafly.com/news/strains-products/6-international-cannabis-strains-worth-seeking-abroad Bongme
  18. Hi New studies show that legal cannabis access reduces opioid abuse Scientific data is growing nearly by the day in support of the notion that legalized cannabis can mitigate opioid use and abuse. For instance, among states where medical cannabis access is permitted, patients routinely lessen their opioid intake. According to data published this week by the Minnesota Department of Health, among those patients known to be taking opiate painkillers upon their enrollment into the program, 63 percent “were able to reduce or eliminate opioid usage after six months.” Minnesota’s findings are hardly unique. In 2016 there was data gathered from patients enrolled in Michigan’s cannabis access program reported that marijuana treatment “was associated with a 64 percent decrease in opioid use, decreased number and side effects of medications, and an improved quality of life.” A review of state-registered patients from various northeastern states yielded similar results, finding, 77 percent of respondents acknowledged having reduced their use of opioids following cannabis therapy. A significant percentage of respondents also reported decreasing their consumption of anti-anxiety medications (72 percent), migraine-related medications (67 percent), sleep aids (65 percent), and antidepressants (38 percent). A 2017 assessment of medical cannabis patients in Illinois revealed that participants in the state-run program frequently reported using marijuana "as an alternative to other medications -- most commonly opioids, but also anticonvulsants, anti-inflammatories, and over-the-counter analgesics." New Mexico patient data reports: Compared to non-users, medical cannabis enrollees "were more likely either to reduce daily opioid prescription dosages between the beginning and end of the sample period (83.8 percent versus 44.8 percent) or to cease filling opioid prescriptions altogether (40.5 percent versus 3.4 percent)." Two just-published clinical trials from Israel — where medical cannabis use is legally permitted — further affirm this phenomenon. In the first study, which assessed cannabis use among the elderly, investigators reported that over 18 percent of the study's participants "stopped using opioid analgesics or reduced their dose" over a six-month period. They concluded, "Cannabis can decrease the use of other prescription medicines, including opioids." In the second trial, which assessed the safety and efficacy of cannabis in a cohort of over 1,200 cancer patients, scientists reported that nearly half of respondents reported either decreasing or eliminating their use of opioids during the treatment period Another recently published clinical trial provides insight into explaining this relationship. Investigators from Columbia University’s Medical Center assessed the efficacy of low doses of inhaled cannabis and sub-therapeutic doses of oxycodone on experimentally-induced pain in a double-blind, placebo-controlled model. Researchers assessed subjects’ pain tolerance after receiving both substances separately or in concert with one another. While neither the administration of cannabis nor oxycodone alone significantly mitigated subjects’ pain, the combined administration of both drugs did so effectively. Authors determined, “Both active cannabis and a low dose of oxycodone (2.5 mg) were sub-therapeutic, failing to elicit analgesia on their own; however, when administered together, pain responses … were significantly reduced, pointing to the opioid-sparing effects of cannabis.” They concluded, “Smoked cannabis combined with an ineffective analgesic dose of oxycodone produced analgesia comparable to an effective opioid analgesic dose without significantly increasing cannabis abuse liability.” The data is consistent and clear. For many patients, cannabis offers a viable alternative to opioids. It is time for the administration to stop placing political ideology above the health and safety of the American public, and to acknowledge the well-established efficacy of medical marijuana in the treatment of chronic pain. http://thehill.com/opinion/healthcare/376643-new-studies-show-that-legal-cannabis-access-reduces-opioid-abuse Bongme
  19. Hi Women and Men Consume Cannabis In Nearly Equal Numbers: And Other Stats That Will Blow Your Mind As legalization spreads throughout the nation, the cannabis industry is gaining credibility in multiple sectors, including education, testing and consumer data. I recently spoke with Linda Gilbert, Managing Director of Consumer Insights for BDS Analytics, a Colorado-based company specializing in cannabusiness-driven data, who emphasized that, despite the stereotypes, “There is no one cannabis consumer.” There are cannabis users from all walks of life; they just don’t talk about their use in the same way as, say, a twenty-year-old college student does. BDS Analytics has data for days—prepare to have your mind blown by these stats. As someone in the industry, even I was shocked by what Linda was telling me. But hey, numbers don’t lie. The following figures are based on information gathered from adults 21 and over in California, Washington, Oregon and Colorado last year. BDS Analytics groups participants into three categories: Consumers: Someone who has “consumed cannabis within the past six months.” Acceptors: Someone who has “not consumed cannabis within the past six months, but would consider [doing so] in the future.” Rejecters: Someone who has “not consumed cannabis within the past six months and would not consider [doing so] in the future.” Participant category breakdown: Consumers – 28% Acceptors – 34% Rejecters – 38% Yes, Rejecters make up the largest percentage here, but I think it’s more significant to look at the Consumer and Acceptor groups. Together, that means that 62% of participants either partake in cannabis, or would partake in cannabis. That’s huge! And we all know the “lazy stoner” stereotype—that we’re unemployed (or underemployed), unambitious, you name it. But as Linda declared, “People who use cannabis make more money!” See for yourself: Average annual household income Consumers – $72.5.1k Acceptors – $69.1k Rejecters – $69.6k Linda also shocked me with some gender breakdowns. I’ve covered women in cannabis frequently here at DOPE, and have had the pleasure to interview scores of successful women who love weed, but I still figured smoker stats would skew wildly male. Men consume more cannabis than women, yes, but not by as wide of a margin as I anticipated: Gender Breakdown Consumers – 56% male | 44% female Acceptors – 44% male | 56% female Rejecters – 39% male | 61% female The “young stoner” stereotype has also proved false. Linda noted that the average age for smokers in the four states is 42—hardly the twentysomething toker cliché. In their age breakdowns, the highest percentage of Consumers fell in the age 25-34 category with 30%; Acceptors in the 65+ category with 22%; and Rejecters in the 65+ 29%. The Consumer stats aren’t surprising, but it’s remarkable that the age group most interested in trying cannabis happens to be 65+. Other insights include: Millennials are more likely to use cannabis for anxiety and to feel happy (social purposes) while Baby Boomers tend to use cannabis for pain relief. 70% of cannabis users prefer inhalable consumption (bongs, vapes, etc.) but 24% prefer edibles, 4% prefer topicals and 1% prefer “other.” Those who have never used cannabis before or haven’t used cannabis in some time are more likely to consume edibles than any other consumption method. Linda predicts that as more Baby Boomers age and cannabis becomes less stigmatized, edibles will have their heyday, as they’re discrete, precise and provide the option to microdose. Keep an eye out for more innovation in this arena targeted at newbies and older folks, specifically with CBD products. Regardless of age, cannabis is most often used in the evening before bed. 35% of participants report consuming before bed, while 28% consume in the morning (with the rest of participants reporting afternoon usage or multiple sessions throughout the day). People who consume cannabis are more likely to describe themselves as socially conscious; compared to other industries, cannabis consumers are more interested in how things are grown/processed and will pay more for a better, safer product that’s eco-friendly, local—the so-called “cannasseurs.” Mind blown? Me, too. And I write and edit cannabis stories for a living! These stats are proof that, as Linda affirmed, there truly isn’t one single cannabis user. We aren’t lazy, we aren’t mostly men, and we are successful members of society. Put that in your pipe and smoke it! https://www.dopemagazine.com/bds-analytics/ Bongme
  20. Hi Smoking cannabis leads to less tobacco and alcohol consumption on campus Researchers from Oregon conducted a study regarding the effects of legalizing recreational marijuana on the consumption of alcohol and cigarettes on school campuses. In the wake of Oregon’s recent legalization of recreational cannabis, researchers have conducted several studies related to the effects of the legalization on the population. Many cannabis advocates will bring up the fact that cannabis consumption will often lower the consumption of other substances such as alcohol and tobacco. Now we finally know for a fact that this is true, as researchers from Oregon have found a firm relationship between the two. The study is named: “Changes in undergraduates’ marijuana, heavy alcohol and cigarette use following legalization of recreational marijuana use in Oregon”. The study was conducted by Oregon State University researchers David C. R. Kerr, Harold Bae, Sandi Phibbs and Adam C. Kern, who are also the authors of the study. According to their findings: In the combined data trends over time indicated decreasing rates of 30-day cigarette use (from 12.9 to 8.6%) and any heavy alcohol use (from 55.4 to 47.9%). The researchers from the Oregon State University also pointed out that the rates of marijuana use increased from 2015 at six of the seven universities, a trend that was significant overall. In fact, the rate of marijuana use among Oregon’s students also climbed when compared to university and college students from other states. https://greencamp.com/smoking-cannabis-leads-less-cigarettes-alcohol-consumption/ Bongme
  21. Hi How Medical Cannabis Can Be A Silver Bullet For Neuropathy Neuropathy manifests in different ways depending on the sort of nerve damage involved. Neuropathy is a generalized term which signifies exhibited symptoms of nerve damage in human beings—neuropathic pain is one of these symptoms. Neuropathy pain arises from a wide variety of sources that all stem from nerve injury, including: “diabetes mellitus…infections, alcoholism, traumatic injuries, autoimmune diseases, medications, infections, tumors, and inherited disorders”. Due to the aforementioned life afflictions, neuropathy manifests in different ways depending on the sort of nerve damage involved with each specific case. When a patient’s neuropathic symptoms are manifested in the form of physical pain, the resultant condition is often referred to under the umbrella term of “chronic pain”. Taken as a whole, neuropathy and neuropathic pain have no cure—modern day medical research into these disorders exists to better the lives of those patients suffering from these afflictions. For the most part, doctors and patients are looking to medical marijuana as a non-addictive, unobtrusive pain medication that stands in stark contradiction to opioids and other debilitating prescription drugs. n 2014 the World Congress assembled in Buenos Aires, Argentina to discuss the scientific validity of medical marijuana as a pain medicine—neuropathic pain was one of the disorders discussed at the assembly. Mark Ware, who works as “a pain clinician at McGill University, Montreal, Canada” represented the pro-cannabis side of the symposium. Interestingly, Ware argued that medical marijuana is beneficial in neurological pain management as THC and CBD react with the theoretical and somewhat contested endocannabinoid systems in the human body. To illustrate, Ware stated at the assembly: “Throughout the nervous system, endogenous cannabinoids act as synaptic circuit breakers…Because their receptors are widespread, cannabinoids, whether endogenous, plant-derived, or synthetic, regulate neurotransmission in many circuits, including pain producing pathways”. Speculation and scientific jargon aside, there seems to be enough evidence of the beneficial effects of cannabis in relation to neuropathic pain to warrant more research. Various studies have shown that medical marijuana has proven efficacious in lessening pain levels for neuropathic pain patients where other prescription medications have proven un-effective. To illustrate, patients afflicted with diabetes, multiple sclerosis, cancer, central neuropathic pain, and HIV all report that various forms of cannabis use greatly reduce their pain symptoms. More specifically, a similar study reports that smoking marijuana was reported effective for pain management in “12 of 15 chronic pain patients”. In a little known arena of the medical marijuana movement is the fact that FDA approved, synthetic THC compounds have been both legal and prescribed in the United States since 1985—a majority of mainstream medical studies into cannabis have been a result of these drugs. For the most part, these synthesized marijuana compounds have been only prescribed to treat nausea and anorexia for terminally ill cancer and HIV patients. However, many doctors prescribe these meds for chronic / neurological pain as well, even though it is not explicit on prescription labelling and paperwork. Moreover, the Canadian medical field has developed and prescribed a pain medication derived from synthesized THC and CBD that they labeled “nabiximols”. In a somewhat ironic twist, many medical professionals feel that synthesized cannabis products are safer, for both the short and long term use, than traditional plant-based organic cannabis flowers. The irony in this concept is evident as the U.S. government has only allowed for medical testing in relation to synthesized THC and CBD compounds, while criminalizing the use of a simple plant. https://thefreshtoast.com/cannabis/how-medical-cannabis-can-be-a-silver-bullet-for-neuropathy/ Bongme
  22. Hi A startup that makes cannabis oil for vaping wants to be America's first $1 billion 'marijuana unicorn' Cura Cannabis Solutions, a startup that makes marijuana oil for vape cartridges, wants to be the first US company in the cannabis industry to achieve elusive "unicorn" status with a billion dollar valuation. "We've had a lot of nicknames. 'Unicorn' is definitely a new one," said Cura president and cofounder Cameron Forni. Cura is currently raising funding at a $400 million valuation, which represents a 1,300% increase from its valuation in 2016 and puts it ahead of the combined market value of the two biggest publicly traded marijuana companies in the US: Terra Tech and Kush Bottles. The Oregon-based company closed the year with $40.5 million in sales, and it predicts revenue will rise to $120 million in 2018 as California's recreational marijuana market comes online. Sales of recreational marijuana began in California on January 1, and the state market is expected to haul $3.7 billion in revenue this year as dispensaries pop up in new cities and counties. Cura, which operated in California's medical marijuana market, is positioned to piggyback on the market's success because it already has distribution there. The vaping market is also exploding. In California, vaporizers account for 32% of sales on Eaze, a marijuana delivery service. In 2017, 72% of millennial Eaze customers bought a vaporizer. Cura's colossal growth stems from a decision it made early on to focus exclusively on cannabis oil, a product that's highly concentrated in the chemical compounds found on the outside of the plant. The company does not grow its own marijuana, but sources it from third-party farmers. The company's signature line of vape cartridges, Select Oil, uses a Japanese organic cotton wick that absorbs the oil through its fibers and delivers it to a heating chamber. According to Forni, the system allows users to take quick draws without the burned taste of a standard cotton wick. Select Oil offers over a dozen formulations with various potencies, flavors, and desired effects. Its biggest seller is a $60 cartridge called Select Elite, which has the highest concentration of THC, the psychoactive ingredient in marijuana, of all its vape cartridges. Cura has been able to scale quickly by having a broad supply chain. In 2017, there were 240 licensed marijuana farms in Oregon, and 180 of them sold all of their trim (plant material that's leftover from trimming the marijuana bud) to Cura for making oil, according to the company. Some cannabis brands say that being vertically integrated — growing the plant that's processed for oil or other products — allows for greater quality control. Brands also pocket a bigger profit, because they don't have to share the revenue with farmers and middlemen distributors. "What other industry does everything from production to processing to retail?" said Forni, who got into the cannabis industry after working on agriculture technology. "In cannabis, these companies want to be the best at everything. It's very difficult to be the best at everything." Cura sells its products in California, Nevada, Oregon, and is eyeing an expansion to Arizona, Florida, New Jersey, and Ohio. It also provides oil wholesale to marijuana edibles makers. Cura has been hiring like crazy to keep up with new market demand, growing from 200 to 285 employees since December. Forni spends much of his time commuting between headquarters in Portland and Cura's outposts in California and Nevada. It's like "being strapped to a rocketship and trying to keep your eyes open," Forni said. Cura's CEO, Nitin Khanna, has remained at the helm of the company in spite of allegations leveled against him. In 2014, Khanna settled a civil suit accusing him of sexual battery and rape. http://uk.businessinsider.com/cura-cannabis-solutions-marijuana-oil-company-2018-1 Bongme
  23. hi My last post until Monday have a great weekend and stay safe The scientist leading the largest marijuana study in history says it's '5x stronger' than in 1980 — but there's a catch An increasing number of Americans live in states where recreational marijuana is legal. CU Boulder psychiatry professor Christian Hopfer is helping lead one of the largest and most long-term studies of marijuana in history. He says marijuana has gotten up to 5 times stronger since the 1980s, but tracking THC potency over time can be tricky. One in five Americans lives in a state where it's legal to use marijuana without a doctor's prescription. Yet we know surprisingly little about the drug's effects on our health. Rumors abound, while the science is sparse. One of the most common rumors is that marijuana today is stronger than it was in the 1970s and 80s. The truth: yes and no. Dispensaries in some states are routinely selling flower that is "at least five times as strong" as it was 40 years ago, Christian Hopfer, a professor of psychiatry at the University of Colorado at Boulder's Anschutz Medical Campus and one of the lead researchers on a forthcoming $5.5-million study of cannabis, told Business Insider. Hopfer's study will be the largest and most long-term analysis of cannabis to date. Hopfer's research has taken him to dispensaries around the state of Colorado, where he said he's seen a variety of marijuana sold with a content breakdown of around 25% THC, the active ingredient in marijuana that's responsible for the high. "It used to be 2-5%, so this stuff is potent," Hopfer said. That's not just true in Colorado. The THC content of marijuana across the US has tripled since 1995, according to a large recent study. For the study, researchers at the University of Mississippi reviewed close to 39,000 samples of cannabis that had been seized across the country by the Drug Enforcement Administration. While THC levels hovered around 4%, on average, in 1995, they skyrocketed to roughly 12% in 2014. Meanwhile, the CBD content in marijuana — the part that's responsible for many of the drug's therapeutic effects — has dropped, the researchers found, shifting the ratio of THC to CBD from 14:1 in 1995 to about 80:1 in 2014. Still, tracking THC potency over time can be tricky. The older a weed sample gets, the more its THC appears to degrade. How it is stored matters too. These are two barriers that could be interfering somewhat with the metrics on pot's potency. A 2012 review of 17 studies analyzing marijuana potency, for example, noted that most of the studies they reviewed did "not describe relevant information about the features (i.e. conservation status and age of the sample) of the analyzed ... cannabis samples." Nevertheless, most researchers agree that weed appears to be getting progressively stronger, although they differ in opinion about precisely how much. There's another issue at play here. While researchers might be able to conclude that weed is getting stronger, they can't necessarily say whether or not people are increasing their dose — or by how much. A 2014 study published in the journal Addiction, for example, found that regular weed users naturally adjust their consumption somewhat based on potency, inhaling less smoke when the marijuana is higher in THC. Despite taking smaller inhales, however, those users still took in a higher THC dose. The researchers were not able to draw any definitive conclusions about the potential ties between higher doses and addiction. A more important predictor of addiction, they concluded, was people's individual smoking behavior (i.e. how many puffs they took, how much smoke they inhaled, and how long their puffs lasted). In this setting, a new approach to addressing cannabis — and its dosage — is desperately needed, Hopfer said. "I think we’ve dealt with marijuana historically from a criminal justice perspective, but if you switch to an environment where it's legal, you switch to a public health perspective. And to do that right, we need more scientific research." http://uk.businessinsider.com/marijuana-has-gotten-stronger-more-potent-research-science-2017-10 Vid On Link Bongme
  24. Hi Female Cannabis Users Smarter Than Those Who Don’t? Could it be that cannabis actually makes women smarter? This brand new study has some interesting findings A new study is suggesting that women who use cannabis regularly have higher IQs than those who don’t… The Journal of Epidemiology and Community Health took a close look at 800 female participants, focusing on intelligence, grades, smoking habits etc. The Journal found that as well as the regular cannabis users having a higher IQ than the general public, women with a 50 percent higher IQ were likely to use cannabis regularly. The study leaders were shocked to find the results, and were left scrambling for a “why.” There are some good guesses, but to date, no on is totally sure. The main crux of it surrounds women who use cannabis being more open to new experiences. That being the case, many suggest that using cannabis regularly may raise IQ as a result of this openness. Often, it is thought, women who use cannabis regularly are more inspired, have more get up and go, and are more driven to experience new things. Coupled with the fact that cannabis is healthy, depending on how it is consumed, it bodes well for intelligent people who prefer natural remedies to dangerous meds prescribed by doctors. While the study presents many great questions it stops short of offering many solid answers. Yes the participants were smarter in terms of IQ if they use cannabis but really the question is why? Is it really to do with this new experience theory or is there more to it? Could it be related to a change of brain chemistry or something even more medical than that? While we may not have all the answers right now, studies like these are a step in the right direction when it comes to understanding the numerous health benefits of cannabis, whether medically, or it seems, recreationally. http://www.cannatech.news/2017/10/04/female-cannabis-users-smarter-dont/ Bongme
  25. Hi Those Stoned Climbers Have More to Teach Us About Cannabis Consumption Than You Might Think vogue magazine Cannabis is slowly becoming a mainstream product as state laws continue to change and brands launch innovative lifestyle offerings around the psychotropic plant. (Think: Laced lip balms, snaked-skin joint holders, and vegan dark chocolate caramels sprinkled with matcha salt.) But on Saturday, when four hikers summited Scafell Pike in England, the country’s tallest mountain, and got too high to climb down, all the old stoner stereotypes came streaming across the Twittersphere. The group had to be rescued after consuming too much cannabis and becoming “incapacitated,” Cumbria police said in a statement. The British authorities deployed mountain rescue to bring the hikers back safely down to earth. The incident sparked public outrage. This news, while perhaps a small setback for an industry looking to distance itself from the drug’s less illustrious connotations and position itself at the forefront of the booming wellness movement with cannabis-infused recipe books and yoga retreats, is not the only time in recent years that consumption of a marijuana product has earned notoriety in the media. In 2009, Michael Phelps was suspended from swimming for three months after a British tabloid ran a full page picture of the Olympian smoking pot out of a bong. He was 23. Leading ultra-marathoner Jenn Shelton sparked ethical debate when she told the Wall Street Journal that she uses cannabis in her training. And the renowned New York Times columnist Maureen Dowd made waves when she wrote about her experience with edibles: after consuming about eight times the recommended dosage while in Colorado, she said, she thought she was dying. (According to the National Institute on Drug Abuse, you cannot die from consuming too much marijuana—cannabis is not lethal on its own—but users can experience panic attacks, paranoia, impaired judgement and motor skills and other unpleasant effects.) So, cannabis: A wellness product or an intoxicating drug? According to a growing number of experts, it can be either, depending on who you are and your mental history (cannabis is not recommended for people with serious mental conditions, including schizophrenia), and how cannabis affects your mind and body. What you're consuming (a few puffs from a vape pen or a bite of a low-dose edible will affect you differently than pulls from a joint or bong), where you are and how much you consume also matters greatly. And thanks to its entrance into the realm of legally controlled substances, with about 29 states and Washington, D.C. having some kind of state-regulated medical marijuana program, and eight states with recreational marijuana laws, there is an increasing body of evidence that, paired with a few simple rules, can help make the gray area less hazy. Dr. Perry Solomon, MD, a board-certified anesthesiologist who is also the Chief Medical Officer of HelloMD, one of the industry's largest online communities that connects patients who suffer from chronic pain and a range of other illnesses with doctors who can offer tailored medical marijuana recommendations, agrees. “For some people, cannabis can help them attain a psychological space that blocks out extraneous things and focus on their mind, body and one repetitive motion,” answers Solomon when asked whether or not cannabis and wellness can go hand-in-hand. Such potential benefits may make it well-suited to mind-body practices like meditation; and a new wave of exercise retreats, yoga studios, and sporting events and gyms (see The 420 Games and Power Plant Fitness) are exploring its role in mild forms of exercise. However you plan to incorporate it into an active lifestyle, experts stress that the key to reaping its self-care benefits may lie in treating the drug with the same respect for dosage and potency as one might any other controlled substance, from alcohol to pharmaceuticals. “No one recommends climbing 3,000 feet and getting stoned,” says Dr. Solomon. “You also need to realize that cannabis can affect you differently depending on what you’re doing, what you ate, and yes, what altitude you’re used to. You can use the same [marijuana] product one day and feel a different affect another day.” For those living where it's legal, here are a few expert-approved ground rules on how to find wellness in cannabis. Start Low, Go Slow The mantra is pasted on billboards and signs across states like Colorado for a reason. While those dipping into the drug for the first time should consult a medical professional, since there are no official guidelines as to what constitutes a proper dose universally, people without a tolerance to THC should generally stick between 2 mg and 2.5 mg for their first couple of times until they're used to the effects, according to Solomon. Satori, which makes medical-grade cannabis-infused edibles out of coffee beans, blueberries and California raisins, touts a micro-dosing friendly bite ranging from 1 milligram per piece up to 10mg. Know Your Dose Dosing matters. Hmbdlt, a vape pen company with the tagline "delivering health and happiness" in Santa Barbara, makes hospital-white, precise low-dose pens that vibrate after a modest 2.25mg of THC oil is dispensed. The system is offered via a range of six formulas, including Sleep, which is developed out of a sleep-promoting terpene blend that helps calm the body and mind, and Arouse, which claims to elevate moods thanks to its ultra-relaxing THC blend of linalool and farnesene terpenes, delivered along with a floral and green apple-like aroma. "Different people require different doses of medicine and it's the same with cannabis," says Gunner Winston, the company's CEO. "That's our focus: dosing technology.” Try CBD-Only Alternatives Instead If you aren’t ready to feel the plant’s psychotropic effects, topicals (lotions, balms, and oils) and treats infused with CBD—the non-psychoactive cannabinoid with medicinal qualities such as anti-inflammation—are a way to tread lightly into the lifestyle because neither will get you high. Cindy Capobianco, co-founder of Lord Jones, the luxe cannabis-infused as well as hemp-derived CBD-infused line of edibles and topicals out of California that has been collaborating on wellness events with Equinox, says she and her husband Rob took their time before putting their low-dose, CBD-rich gum drops and cooling body lotions on shelves. “We developed and designed our products for people who were cannabis curious, but also fearful of having a bad experience,” says Capobianco. Other brands offering high-end topicals in an effort to ease-in the inexperienced include Marley Natural, which also has a line of branded marijuana, Apothecanna, one of the industry's first all-natural beauty lines derived by cannabis and therapeutic-grade essential oils, and Kiva, a cannabis-infused chocolatier that recently launched its own line of CBD-only confections. Their tagline? "A higher chocolate experience." https://www.vogue.com/article/stoned-climbers-best-cannabis-lifestyle-brands-dose-vape-pens-wellness-california-scafell-pike-england Bongme